Travis B DeSa1, Muhannad A Abbasi2, Julie A Blaisdell2, Kai Lin2, Jeremy D Collins3, James C Carr2, Michael Markl4. 1. Northwestern University Feinberg School of Medicine, Department of Diagnostic Radiology, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA. Electronic address: travis.desa@gmail.com. 2. Northwestern University Feinberg School of Medicine, Department of Diagnostic Radiology, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA. 3. Northwestern University Feinberg School of Medicine, Department of Diagnostic Radiology, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA; Mayo Clinic, Department of Radiology, Rochester, MN, USA. 4. Northwestern University Feinberg School of Medicine, Department of Diagnostic Radiology, 737 N. Michigan Avenue Suite 1600, Chicago, IL 60611, USA; Northwestern University McCormick School of Engineering, Department of Biomedical Engineering, 2145 Sheridan Rd, Evanston, IL 60208, USA.
Abstract
BACKGROUND: Cardiac Allograft Vasculopathy (CAV) is a major cause of chronic cardiac allograft failure. Invasive coronary angiography (ICA) and intravascular ultrasound (IVUS) are the current diagnostic methods. Myocardial perfusion MRI has become a promising non-invasive method to evaluate myocardial ischemia, but has not been thoroughly validated in CAV. Our objective was to assess the repeatability of myocardial rest-perfusion MRI in healthy volunteers and its feasibility in detecting CAV in transplant patients (Tx). METHODS: Twelve healthy volunteers and twenty transplant patients beyond the first year post- transplant underwent cardiac MRI at 1.5 T at rest including first-pass perfusion imaging in short axis (base, mid, apex) after injection of gadolinium. Volunteers underwent repeated cardiac MRI on different days (interval = 15.6 ± 2.4 days) to assess repeatability. Data analysis included semi-automatic contouring of endocardial and epicardial borders of the left ventricle (LV) and quantification of peak perfusion, time-to-peak (TTP) perfusion, and upslope of the perfusion curve. RESULTS: Between scans and re-scans in healthy volunteers, peak signal intensity, slope, and TTP demonstrated moderate agreement (ICC = 0.53, 0.48, and 0.59, respectively; all, p < .001). Peak signal intensity, slope, and TTP were moderately variable with COV values of 23%, 42%, and 35%, respectively. Peak perfusion was significantly reduced in CAV positive (n = 9 Tx patients) compared to CAV negative (n = 11 Tx patients) groups (90.7 ± 27.0 vs 139.5 ± 30.2, p < .001). CONCLUSION: Cardiac MRI is a moderately repeatable method for the semi-quantitative assessment of first-pass myocardial perfusion at rest. Semi-quantitative surrogate markers of LV perfusion could play a role in CAV detection.
BACKGROUND:Cardiac Allograft Vasculopathy (CAV) is a major cause of chronic cardiac allograft failure. Invasive coronary angiography (ICA) and intravascular ultrasound (IVUS) are the current diagnostic methods. Myocardial perfusion MRI has become a promising non-invasive method to evaluate myocardial ischemia, but has not been thoroughly validated in CAV. Our objective was to assess the repeatability of myocardial rest-perfusion MRI in healthy volunteers and its feasibility in detecting CAV in transplant patients (Tx). METHODS: Twelve healthy volunteers and twenty transplant patients beyond the first year post- transplant underwent cardiac MRI at 1.5 T at rest including first-pass perfusion imaging in short axis (base, mid, apex) after injection of gadolinium. Volunteers underwent repeated cardiac MRI on different days (interval = 15.6 ± 2.4 days) to assess repeatability. Data analysis included semi-automatic contouring of endocardial and epicardial borders of the left ventricle (LV) and quantification of peak perfusion, time-to-peak (TTP) perfusion, and upslope of the perfusion curve. RESULTS: Between scans and re-scans in healthy volunteers, peak signal intensity, slope, and TTP demonstrated moderate agreement (ICC = 0.53, 0.48, and 0.59, respectively; all, p < .001). Peak signal intensity, slope, and TTP were moderately variable with COV values of 23%, 42%, and 35%, respectively. Peak perfusion was significantly reduced in CAV positive (n = 9 Tx patients) compared to CAV negative (n = 11 Tx patients) groups (90.7 ± 27.0 vs 139.5 ± 30.2, p < .001). CONCLUSION: Cardiac MRI is a moderately repeatable method for the semi-quantitative assessment of first-pass myocardial perfusion at rest. Semi-quantitative surrogate markers of LV perfusion could play a role in CAV detection.
Authors: Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim Journal: J Am Coll Cardiol Date: 2006-03-27 Impact factor: 24.094
Authors: Christopher A Miller; Saqib Chowdhary; Simon G Ray; Jaydeep Sarma; Simon G Williams; Nizar Yonan; Tarun K Mittal; Matthias Schmitt Journal: Circ Cardiovasc Imaging Date: 2011-09 Impact factor: 7.792
Authors: Giacomo Tarroni; Cristiana Corsi; Patrick F Antkowiak; Federico Veronesi; Christopher M Kramer; Frederick H Epstein; James Walter; Claudio Lamberti; Roberto M Lang; Victor Mor-Avi; Amit R Patel Journal: Radiology Date: 2012-08-14 Impact factor: 11.105
Authors: William F Fearon; Atsushi Hirohata; Mamoo Nakamura; Helen Luikart; David P Lee; Randall H Vagelos; Sharon A Hunt; Hannah A Valantine; Peter J Fitzgerald; Paul G Yock; Alan C Yeung Journal: J Heart Lung Transplant Date: 2006-05-24 Impact factor: 10.247
Authors: K F Kofoed; J Czernin; J Johnson; J Kobashigawa; M E Phelps; H Laks; H R Schelbert Journal: Circulation Date: 1997-02-04 Impact factor: 29.690
Authors: Lars H Lund; Kiran K Khush; Wida S Cherikh; Samuel Goldfarb; Anna Y Kucheryavaya; Bronwyn J Levvey; Bruno Meiser; Joseph W Rossano; Daniel C Chambers; Roger D Yusen; Josef Stehlik Journal: J Heart Lung Transplant Date: 2017-07-20 Impact factor: 10.247
Authors: Mandeep R Mehra; Maria G Crespo-Leiro; Anne Dipchand; Stephan M Ensminger; Nicola E Hiemann; Jon A Kobashigawa; Joren Madsen; Jayan Parameshwar; Randall C Starling; Patricia A Uber Journal: J Heart Lung Transplant Date: 2010-07 Impact factor: 10.247
Authors: M R Mehra; H O Ventura; D D Stapleton; F W Smart; T C Collins; S R Ramee Journal: J Heart Lung Transplant Date: 1995 Jul-Aug Impact factor: 10.247
Authors: Jon A Kobashigawa; Daniel F Pauly; Randall C Starling; Howard Eisen; Heather Ross; Shoei-Shen Wang; Bernard Cantin; James A Hill; Patricia Lopez; Gaohong Dong; Stephen J Nicholls Journal: JACC Heart Fail Date: 2013-09-11 Impact factor: 12.035